Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cardlytics, Inc. | CYX | Oct 8, 2024 | 2.57 | +0.63 |
Cardno Limited | DZ5 | Oct 8, 2024 | 0.17 | -2.02 |
Carebook Technologies Inc. | PMM1 | Oct 8, 2024 | 0.03 | 0.00 |
CareCloud, Inc. | MTB0 | Oct 8, 2024 | 2.20 | +4.76 |
CareCloud, Inc. - 11% Series A Cumulative Redeemable Perpetu | MTBB | Oct 8, 2024 | 10.40 | -2.80 |
CareDx, Inc. | 1K9 | Oct 8, 2024 | 29.02 | +4.13 |
Careium AB | I81 | Oct 8, 2024 | 2.73 | 0.00 |
Carel Industries S.p.A. | CIG | Oct 8, 2024 | 18.96 | 0.00 |
CareRx Corporation | 29C1 | Oct 8, 2024 | 1.27 | +0.79 |
CareTrust REIT, Inc. | 7XC | Oct 8, 2024 | 27.40 | -0.72 |
Cargojet Inc | CJ8A | Oct 8, 2024 | 89.50 | 0.00 |
Cargotec | C1C1 | Oct 8, 2024 | 52.25 | -2.06 |
Cargotec | C1C | Oct 8, 2024 | 75.10 | 0.00 |
CarGurus, Inc. - Class A | 0C6 | Oct 8, 2024 | 26.40 | -0.75 |
Carisma Therapeutics | W2J | Oct 8, 2024 | 0.84 | -0.18 |
Carl Zeiss Meditec A G | AFXA | Oct 8, 2024 | 67.00 | -2.19 |
Carl Zeiss Meditec A G | AFX | Oct 8, 2024 | 65.45 | -4.03 |
Carlisle Companies Incorporated | CLE | Oct 8, 2024 | 419.10 | +2.49 |
Carlsberg | CBGC | Oct 8, 2024 | 21.00 | 0.00 |
Carlsberg A | CBGA | Oct 8, 2024 | 133.50 | -3.61 |
Carlsberg B | CBGB | Oct 8, 2024 | 104.90 | -2.60 |
Carlson Investments SA | 2HB | Oct 8, 2024 | 1.37 | 0.00 |
Carmat | CXT | Oct 8, 2024 | 1.29 | +6.45 |
CarMax Inc | XA4 | Oct 8, 2024 | 65.30 | -1.21 |
Carmila | CUX1 | Oct 8, 2024 | 17.74 | -1.00 |
Carnarvon Petroleum Ltd. | CJB | Oct 8, 2024 | 0.09 | -12.31 |
Carnavale Resources Limited | YBB | Oct 8, 2024 | 0.00 | 0.00 |
Carnegie Clean Energy Limited | CNM1 | Oct 8, 2024 | 0.02 | 0.00 |
Carnival Corporation | CVC1 | Oct 8, 2024 | 17.00 | +3.54 |
Carnival PLC | POH1 | Oct 8, 2024 | 15.38 | +3.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.